Pharmaceutical Johnson & Johnson (J&J) Delay the time of vaccination Coronavirus disease After an error occurred in a production plant, the US authorities Baltimore According to the New York Times, the components of the two different vaccines are mixed together.
Obviously, in this place, belong to the company Emerging biological solutions, About two weeks ago, Johnson & Johnson and AstraZeneca’s vaccine ingredients were “accidentally” mixed, resulting in Missed up to 15 million doses Johnson & Johnson has also forced regulators to postpone the authorization of the factory’s production lines.
The same factory produces two doses Johnson And the products of the pharmaceutical company AstaZeneca, aimed at combating covid-19.
At the same time, Johnson & Johnson decided to strengthen the supervision of Emergent BioSolution to avoid quality problems in future production.
This delay will not affect the doses currently used in the U.S. because they are produced in the U.S. Netherlands, The production line has been approved by the U.S. regulatory agency.
However, it is expected to start in April Johnson According to Baltimore, it will begin mass production at the Baltimore plant, which has now been questioned. New York Times, Cite sources familiar with the matter.
America president, Joe BidenOn Monday, he promised that by April 19, 90% of adults in the United States will be able to make an appointment to receive vaccination against covid-19.